Sprout Pharms Drug Patent Portfolio
Sprout Pharms owns 1 orange book drug protected by 4 US patents Given below is the list of Sprout Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7151103 | Method of treating female hypoactive sexual desire disorder with flibanserin | 09 May, 2028 | Active |
| US8227471 | Treating sexual desire disorders with flibanserin | 09 May, 2023 | Expired |
| US9468639 | Treating sexual desire disorders with flibanserin | 16 Oct, 2022 | Expired |
| US7420057 | Stable polymorph of flibanserin | 01 Aug, 2022 | Expired |
Latest Legal Activities on Sprout Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sprout Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Jan, 2024 | US8227471 |
|
Patent Term Extension Certificate
Critical
| 19 Nov, 2021 | US7151103 |
| FITF set to NO - revise initial setting | 05 Mar, 2021 | US7151103 |
| Notice of Final Determination -Election Required | 05 Mar, 2021 | US7420057 |
| Notice of Final Determination -Election Required | 05 Mar, 2021 | US7151103 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 07 Apr, 2020 | US9468639 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Feb, 2020 | US7420057 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 14 Jan, 2020 | US8227471 |
|
Email Notification
Critical
| 08 Oct, 2019 | US7151103 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 08 Oct, 2019 | US7151103 |
|
Correspondence Address Change
Critical
| 07 Oct, 2019 | US7151103 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 Oct, 2019 | US7420057 |
|
Correspondence Address Change
Critical
| 02 Oct, 2019 | US7420057 |
|
FDA Final Eligibility Letter
Critical
| 03 Jul, 2019 | US7420057 |
|
FDA Final Eligibility Letter
Critical
| 03 Jul, 2019 | US7151103 |
Sprout Pharms's Family Patents
Sprout Pharms Drug List
Given below is the complete list of Sprout Pharms's drugs and the patents protecting them.
1. Addyi
Addyi is protected by 4 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7151103 | Method of treating female hypoactive sexual desire disorder with flibanserin |
09 May, 2028
(3 years from now)
| Active |
| US8227471 | Treating sexual desire disorders with flibanserin |
09 May, 2023
(1 year, 7 months ago)
| Expired |
| US9468639 | Treating sexual desire disorders with flibanserin |
16 Oct, 2022
(2 years ago)
| Expired |
| US7420057 | Stable polymorph of flibanserin |
01 Aug, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Addyi's drug page